US Patent No. 10,987,362

TREATMENT OF FIBROSIS USING FXR LIGANDS


Patent No. 10,987,362
Issue Date April 27, 2021
Title Treatment Of Fibrosis Using Fxr Ligands
Inventorship Stefano Fiorucci, Perugia (IT)
Roberto Pellicciari, Perugia (IT)
Mark Pruzanski, New York, NY (US)
Assignee Intercept Pharmaceuticals, Inc., New York, NY (US)

Claim of US Patent No. 10,987,362

1. A method for treating non-alcoholic steatohepatitis in a subject not suffering from a cholestatic condition, the method comprising the step of administering to the subject an effective amount of tauro-6-ethyl-chenodeoxycholic acid (tauro-6ECDCA).